About Michael William Method
Dr. Michael Method is a board-certified gynecologic oncologist with over 20 years of experience focusing in the surgical management of gynecologic malignancies. He earned his medical degree from Northwestern University School of Medicine, as well as his master’s in public health. He then went on to complete his obstetrics and gynecology residency with the University of California School of Medicine and David Grant USAF Medical Center with further specialization by completing a gynecologic oncology fellowship at the University of Miami School of Medicine. Dr. Method is the Community Health Network director of gynecologic cancer care and network director of oncology research. Dr. Method co-founded the National Ovarian Cancer Coalition as well as the Women’s Task Force and Secret Sisters Society in Michiana, IN. He is passionate about cancer prevention, as well as the opportunity to care and manage patients through their journey when threatened by cancer and its side effects. The opportunity to help dispel the myth of ovarian cancer as “the silent killer” as well as to empower women with prevention knowledge has been a career highlight. Dr. Method is married with five wonderful children and enjoys participating in outdoor activities, including running and triathlons.
University of Miami Leonard M. Miller School of Medicine
Fellowship, Gynecologic Oncology, 1996
David Grant Medical Center
Residency, Obstetrics & Gynecology, 1990
Medical School, Medicine, MD, 1986
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Gynecologic Oncology, 2015
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2014
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer.
Gynecologic Oncology, 2012
Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer.
Gynecologic Oncology, 2005
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Gynecologic Oncology, 2004
Ratings & Reviews
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Community Health Network are displayed.